Global Cell Expansion

Cell Expansion Comprehensive Study by Type (Consumables, Reagents, Media & Serum, Disposables (Tissue Culture Flasks, Bioreactor Accessories, and Others), Instruments (Cell Expansion Supporting Equipment, Bioreactors, Automated Cell Expansion Systems)), Application (Regenerative Medicine, Cell Banking, Cancer Research, Other), End User (Research Institutes, Biopharmaceutical and Biotechnology Companies, Cell Banks, Others), Cell Type (Human Cells (Stem Cells, Differentiated Cells), Animal Cells) Players and Region - Global Market Outlook to 2029

Cell Expansion Market by XX Submarkets | Forecast Years 2024-2029 | CAGR: 18.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Cell Expansion
Cell expansion" can refer to a few different things, depending on the context. To provide you with the most relevant information, I need a bit more context. Growing Focus on R&D for Cell-Based Therapies will help to boost global cell expansion market. Cell expansion is the process of production of cells from a single cell which used therapeutic development, micro-level research of cells and drug screening. Also, cell expansion is mainly used in the treatment of various diseases such as diabetes, rheumatoid arthritis, and others. The upsurge in the prevalence of chronic diseases and development in the number of GMP certified products will act as a major driver of cell expansion market.

AttributesDetails
Study Period2018-2029
Base Year2023
High Growth MarketAsia- Pacific
UnitValue (USD Million)
CAGR18.8%


The competitive landscape in the Ebola Virus Vaccine market is not solely driven by profit motives, but by the overarching goal of global health protection and saving lives. While competition fosters innovation and development, collaboration and equitable access remain key to effectively combating this deadly virus. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Cell Expansion market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific, Inc. (United States), Becton, Dickinson and Company (United States), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (United States), Miltenyi Biotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (United States) and Corning, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are STEMCELL Technologies, Inc. (Canada), Sigma-Aldrich Corporation (United States), Miltenyi Biotec GmbH (Germany), Lonza Group Ltd. (Switzerland) and ATEM Therapeutics (Germany).

Segmentation Overview
AMA Research has segmented the market of Global Cell Expansion market by Type (Consumables, Reagents, Media & Serum, Disposables [Tissue Culture Flasks, Bioreactor Accessories, and Others] and Instruments [Cell Expansion Supporting Equipment, Bioreactors, Automated Cell Expansion Systems]), Application (Regenerative Medicine, Cell Banking, Cancer Research and Other) and Region.



On the basis of geography, the market of Cell Expansion has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by End User, the sub-segment i.e. Research Institutes will boost the Cell Expansion market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Cell Type, the sub-segment i.e. Human Cells [Stem Cells, Differentiated Cells] will boost the Cell Expansion market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing GMP Certifications for Cell Therapy Production Facilities and Rising Government Funds for Cell-Based Research

Market Growth Drivers:
Developing the Incidence of Chronic Diseases and Growing Focus on Regenerative Medicine

Challenges:
Limited understanding of cell behavior

Restraints:
Ethical Concerns Regarding Research in Cell Biology and High Cost for Operations

Opportunities:
Huge Demand for 3D Cell Expansion Technology

Market Leaders and their expansionary development strategies
In October 2023, GE Healthcare teams up with contract manufacturing organizations to offer end-to-end cell expansion solutions for clients developing cell therapies
In November 2023, GE Healthcare introduces a continuous cell expansion platform aimed at optimizing cell quality and yield for high-volume cell therapy production


Key Target Audience
Investors, Medical Research Institutes, Research Organizations and Consulting Companies., Market Research and Consulting Firm and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Consumables
  • Reagents
  • Media & Serum
  • Disposables [Tissue Culture Flasks, Bioreactor Accessories, and Others]
  • Instruments [Cell Expansion Supporting Equipment, Bioreactors, Automated Cell Expansion Systems]
By Application
  • Regenerative Medicine
  • Cell Banking
  • Cancer Research
  • Other
By End User
  • Research Institutes
  • Biopharmaceutical and Biotechnology Companies
  • Cell Banks
  • Others

By Cell Type
  • Human Cells [Stem Cells, Differentiated Cells]
  • Animal Cells

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Developing the Incidence of Chronic Diseases
      • 3.2.2. Growing Focus on Regenerative Medicine
    • 3.3. Market Challenges
      • 3.3.1. Limited understanding of cell behavior
    • 3.4. Market Trends
      • 3.4.1. Growing GMP Certifications for Cell Therapy Production Facilities
      • 3.4.2. Rising Government Funds for Cell-Based Research
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cell Expansion, by Type, Application, End User, Cell Type and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Cell Expansion (Value)
      • 5.2.1. Global Cell Expansion by: Type (Value)
        • 5.2.1.1. Consumables
        • 5.2.1.2. Reagents
        • 5.2.1.3. Media & Serum
        • 5.2.1.4. Disposables [Tissue Culture Flasks, Bioreactor Accessories, and Others]
        • 5.2.1.5. Instruments [Cell Expansion Supporting Equipment, Bioreactors, Automated Cell Expansion Systems]
      • 5.2.2. Global Cell Expansion by: Application (Value)
        • 5.2.2.1. Regenerative Medicine
        • 5.2.2.2. Cell Banking
        • 5.2.2.3. Cancer Research
        • 5.2.2.4. Other
      • 5.2.3. Global Cell Expansion by: End User (Value)
        • 5.2.3.1. Research Institutes
        • 5.2.3.2. Biopharmaceutical and Biotechnology Companies
        • 5.2.3.3. Cell Banks
        • 5.2.3.4. Others
      • 5.2.4. Global Cell Expansion by: Cell Type (Value)
        • 5.2.4.1. Human Cells [Stem Cells, Differentiated Cells]
        • 5.2.4.2. Animal Cells
      • 5.2.5. Global Cell Expansion Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Cell Expansion (Price)
      • 5.3.1. Global Cell Expansion by: Type (Price)
  • 6. Cell Expansion: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Terumo BCT (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck KGaA (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Danaher Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Miltenyi Biotec (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lonza Group Ltd. (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. STEMCELL Technologies Inc. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GE Healthcare (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Corning, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cell Expansion Sale, by Type, Application, End User, Cell Type and Region (value and price ) (2024-2029)
    • 7.1. Introduction
    • 7.2. Global Cell Expansion (Value)
      • 7.2.1. Global Cell Expansion by: Type (Value)
        • 7.2.1.1. Consumables
        • 7.2.1.2. Reagents
        • 7.2.1.3. Media & Serum
        • 7.2.1.4. Disposables [Tissue Culture Flasks, Bioreactor Accessories, and Others]
        • 7.2.1.5. Instruments [Cell Expansion Supporting Equipment, Bioreactors, Automated Cell Expansion Systems]
      • 7.2.2. Global Cell Expansion by: Application (Value)
        • 7.2.2.1. Regenerative Medicine
        • 7.2.2.2. Cell Banking
        • 7.2.2.3. Cancer Research
        • 7.2.2.4. Other
      • 7.2.3. Global Cell Expansion by: End User (Value)
        • 7.2.3.1. Research Institutes
        • 7.2.3.2. Biopharmaceutical and Biotechnology Companies
        • 7.2.3.3. Cell Banks
        • 7.2.3.4. Others
      • 7.2.4. Global Cell Expansion by: Cell Type (Value)
        • 7.2.4.1. Human Cells [Stem Cells, Differentiated Cells]
        • 7.2.4.2. Animal Cells
      • 7.2.5. Global Cell Expansion Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Cell Expansion (Price)
      • 7.3.1. Global Cell Expansion by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cell Expansion: by Type(USD Million)
  • Table 2. Cell Expansion Consumables , by Region USD Million (2018-2023)
  • Table 3. Cell Expansion Reagents , by Region USD Million (2018-2023)
  • Table 4. Cell Expansion Media & Serum , by Region USD Million (2018-2023)
  • Table 5. Cell Expansion Disposables [Tissue Culture Flasks, Bioreactor Accessories, and Others] , by Region USD Million (2018-2023)
  • Table 6. Cell Expansion Instruments [Cell Expansion Supporting Equipment, Bioreactors, Automated Cell Expansion Systems] , by Region USD Million (2018-2023)
  • Table 7. Cell Expansion: by Application(USD Million)
  • Table 8. Cell Expansion Regenerative Medicine , by Region USD Million (2018-2023)
  • Table 9. Cell Expansion Cell Banking , by Region USD Million (2018-2023)
  • Table 10. Cell Expansion Cancer Research , by Region USD Million (2018-2023)
  • Table 11. Cell Expansion Other , by Region USD Million (2018-2023)
  • Table 12. Cell Expansion: by End User(USD Million)
  • Table 13. Cell Expansion Research Institutes , by Region USD Million (2018-2023)
  • Table 14. Cell Expansion Biopharmaceutical and Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 15. Cell Expansion Cell Banks , by Region USD Million (2018-2023)
  • Table 16. Cell Expansion Others , by Region USD Million (2018-2023)
  • Table 17. Cell Expansion: by Cell Type(USD Million)
  • Table 18. Cell Expansion Human Cells [Stem Cells, Differentiated Cells] , by Region USD Million (2018-2023)
  • Table 19. Cell Expansion Animal Cells , by Region USD Million (2018-2023)
  • Table 20. South America Cell Expansion, by Country USD Million (2018-2023)
  • Table 21. South America Cell Expansion, by Type USD Million (2018-2023)
  • Table 22. South America Cell Expansion, by Application USD Million (2018-2023)
  • Table 23. South America Cell Expansion, by End User USD Million (2018-2023)
  • Table 24. South America Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 25. Brazil Cell Expansion, by Type USD Million (2018-2023)
  • Table 26. Brazil Cell Expansion, by Application USD Million (2018-2023)
  • Table 27. Brazil Cell Expansion, by End User USD Million (2018-2023)
  • Table 28. Brazil Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 29. Argentina Cell Expansion, by Type USD Million (2018-2023)
  • Table 30. Argentina Cell Expansion, by Application USD Million (2018-2023)
  • Table 31. Argentina Cell Expansion, by End User USD Million (2018-2023)
  • Table 32. Argentina Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 33. Rest of South America Cell Expansion, by Type USD Million (2018-2023)
  • Table 34. Rest of South America Cell Expansion, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Cell Expansion, by End User USD Million (2018-2023)
  • Table 36. Rest of South America Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 37. Asia Pacific Cell Expansion, by Country USD Million (2018-2023)
  • Table 38. Asia Pacific Cell Expansion, by Type USD Million (2018-2023)
  • Table 39. Asia Pacific Cell Expansion, by Application USD Million (2018-2023)
  • Table 40. Asia Pacific Cell Expansion, by End User USD Million (2018-2023)
  • Table 41. Asia Pacific Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 42. China Cell Expansion, by Type USD Million (2018-2023)
  • Table 43. China Cell Expansion, by Application USD Million (2018-2023)
  • Table 44. China Cell Expansion, by End User USD Million (2018-2023)
  • Table 45. China Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 46. Japan Cell Expansion, by Type USD Million (2018-2023)
  • Table 47. Japan Cell Expansion, by Application USD Million (2018-2023)
  • Table 48. Japan Cell Expansion, by End User USD Million (2018-2023)
  • Table 49. Japan Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 50. India Cell Expansion, by Type USD Million (2018-2023)
  • Table 51. India Cell Expansion, by Application USD Million (2018-2023)
  • Table 52. India Cell Expansion, by End User USD Million (2018-2023)
  • Table 53. India Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 54. South Korea Cell Expansion, by Type USD Million (2018-2023)
  • Table 55. South Korea Cell Expansion, by Application USD Million (2018-2023)
  • Table 56. South Korea Cell Expansion, by End User USD Million (2018-2023)
  • Table 57. South Korea Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 58. Taiwan Cell Expansion, by Type USD Million (2018-2023)
  • Table 59. Taiwan Cell Expansion, by Application USD Million (2018-2023)
  • Table 60. Taiwan Cell Expansion, by End User USD Million (2018-2023)
  • Table 61. Taiwan Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 62. Australia Cell Expansion, by Type USD Million (2018-2023)
  • Table 63. Australia Cell Expansion, by Application USD Million (2018-2023)
  • Table 64. Australia Cell Expansion, by End User USD Million (2018-2023)
  • Table 65. Australia Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Cell Expansion, by Type USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Cell Expansion, by Application USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Cell Expansion, by End User USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 70. Europe Cell Expansion, by Country USD Million (2018-2023)
  • Table 71. Europe Cell Expansion, by Type USD Million (2018-2023)
  • Table 72. Europe Cell Expansion, by Application USD Million (2018-2023)
  • Table 73. Europe Cell Expansion, by End User USD Million (2018-2023)
  • Table 74. Europe Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 75. Germany Cell Expansion, by Type USD Million (2018-2023)
  • Table 76. Germany Cell Expansion, by Application USD Million (2018-2023)
  • Table 77. Germany Cell Expansion, by End User USD Million (2018-2023)
  • Table 78. Germany Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 79. France Cell Expansion, by Type USD Million (2018-2023)
  • Table 80. France Cell Expansion, by Application USD Million (2018-2023)
  • Table 81. France Cell Expansion, by End User USD Million (2018-2023)
  • Table 82. France Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 83. Italy Cell Expansion, by Type USD Million (2018-2023)
  • Table 84. Italy Cell Expansion, by Application USD Million (2018-2023)
  • Table 85. Italy Cell Expansion, by End User USD Million (2018-2023)
  • Table 86. Italy Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 87. United Kingdom Cell Expansion, by Type USD Million (2018-2023)
  • Table 88. United Kingdom Cell Expansion, by Application USD Million (2018-2023)
  • Table 89. United Kingdom Cell Expansion, by End User USD Million (2018-2023)
  • Table 90. United Kingdom Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 91. Netherlands Cell Expansion, by Type USD Million (2018-2023)
  • Table 92. Netherlands Cell Expansion, by Application USD Million (2018-2023)
  • Table 93. Netherlands Cell Expansion, by End User USD Million (2018-2023)
  • Table 94. Netherlands Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 95. Rest of Europe Cell Expansion, by Type USD Million (2018-2023)
  • Table 96. Rest of Europe Cell Expansion, by Application USD Million (2018-2023)
  • Table 97. Rest of Europe Cell Expansion, by End User USD Million (2018-2023)
  • Table 98. Rest of Europe Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 99. MEA Cell Expansion, by Country USD Million (2018-2023)
  • Table 100. MEA Cell Expansion, by Type USD Million (2018-2023)
  • Table 101. MEA Cell Expansion, by Application USD Million (2018-2023)
  • Table 102. MEA Cell Expansion, by End User USD Million (2018-2023)
  • Table 103. MEA Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 104. Middle East Cell Expansion, by Type USD Million (2018-2023)
  • Table 105. Middle East Cell Expansion, by Application USD Million (2018-2023)
  • Table 106. Middle East Cell Expansion, by End User USD Million (2018-2023)
  • Table 107. Middle East Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 108. Africa Cell Expansion, by Type USD Million (2018-2023)
  • Table 109. Africa Cell Expansion, by Application USD Million (2018-2023)
  • Table 110. Africa Cell Expansion, by End User USD Million (2018-2023)
  • Table 111. Africa Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 112. North America Cell Expansion, by Country USD Million (2018-2023)
  • Table 113. North America Cell Expansion, by Type USD Million (2018-2023)
  • Table 114. North America Cell Expansion, by Application USD Million (2018-2023)
  • Table 115. North America Cell Expansion, by End User USD Million (2018-2023)
  • Table 116. North America Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 117. United States Cell Expansion, by Type USD Million (2018-2023)
  • Table 118. United States Cell Expansion, by Application USD Million (2018-2023)
  • Table 119. United States Cell Expansion, by End User USD Million (2018-2023)
  • Table 120. United States Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 121. Canada Cell Expansion, by Type USD Million (2018-2023)
  • Table 122. Canada Cell Expansion, by Application USD Million (2018-2023)
  • Table 123. Canada Cell Expansion, by End User USD Million (2018-2023)
  • Table 124. Canada Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 125. Mexico Cell Expansion, by Type USD Million (2018-2023)
  • Table 126. Mexico Cell Expansion, by Application USD Million (2018-2023)
  • Table 127. Mexico Cell Expansion, by End User USD Million (2018-2023)
  • Table 128. Mexico Cell Expansion, by Cell Type USD Million (2018-2023)
  • Table 129. Cell Expansion: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Cell Expansion: by Type(USD Million)
  • Table 141. Cell Expansion Consumables , by Region USD Million (2024-2029)
  • Table 142. Cell Expansion Reagents , by Region USD Million (2024-2029)
  • Table 143. Cell Expansion Media & Serum , by Region USD Million (2024-2029)
  • Table 144. Cell Expansion Disposables [Tissue Culture Flasks, Bioreactor Accessories, and Others] , by Region USD Million (2024-2029)
  • Table 145. Cell Expansion Instruments [Cell Expansion Supporting Equipment, Bioreactors, Automated Cell Expansion Systems] , by Region USD Million (2024-2029)
  • Table 146. Cell Expansion: by Application(USD Million)
  • Table 147. Cell Expansion Regenerative Medicine , by Region USD Million (2024-2029)
  • Table 148. Cell Expansion Cell Banking , by Region USD Million (2024-2029)
  • Table 149. Cell Expansion Cancer Research , by Region USD Million (2024-2029)
  • Table 150. Cell Expansion Other , by Region USD Million (2024-2029)
  • Table 151. Cell Expansion: by End User(USD Million)
  • Table 152. Cell Expansion Research Institutes , by Region USD Million (2024-2029)
  • Table 153. Cell Expansion Biopharmaceutical and Biotechnology Companies , by Region USD Million (2024-2029)
  • Table 154. Cell Expansion Cell Banks , by Region USD Million (2024-2029)
  • Table 155. Cell Expansion Others , by Region USD Million (2024-2029)
  • Table 156. Cell Expansion: by Cell Type(USD Million)
  • Table 157. Cell Expansion Human Cells [Stem Cells, Differentiated Cells] , by Region USD Million (2024-2029)
  • Table 158. Cell Expansion Animal Cells , by Region USD Million (2024-2029)
  • Table 159. South America Cell Expansion, by Country USD Million (2024-2029)
  • Table 160. South America Cell Expansion, by Type USD Million (2024-2029)
  • Table 161. South America Cell Expansion, by Application USD Million (2024-2029)
  • Table 162. South America Cell Expansion, by End User USD Million (2024-2029)
  • Table 163. South America Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 164. Brazil Cell Expansion, by Type USD Million (2024-2029)
  • Table 165. Brazil Cell Expansion, by Application USD Million (2024-2029)
  • Table 166. Brazil Cell Expansion, by End User USD Million (2024-2029)
  • Table 167. Brazil Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 168. Argentina Cell Expansion, by Type USD Million (2024-2029)
  • Table 169. Argentina Cell Expansion, by Application USD Million (2024-2029)
  • Table 170. Argentina Cell Expansion, by End User USD Million (2024-2029)
  • Table 171. Argentina Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 172. Rest of South America Cell Expansion, by Type USD Million (2024-2029)
  • Table 173. Rest of South America Cell Expansion, by Application USD Million (2024-2029)
  • Table 174. Rest of South America Cell Expansion, by End User USD Million (2024-2029)
  • Table 175. Rest of South America Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 176. Asia Pacific Cell Expansion, by Country USD Million (2024-2029)
  • Table 177. Asia Pacific Cell Expansion, by Type USD Million (2024-2029)
  • Table 178. Asia Pacific Cell Expansion, by Application USD Million (2024-2029)
  • Table 179. Asia Pacific Cell Expansion, by End User USD Million (2024-2029)
  • Table 180. Asia Pacific Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 181. China Cell Expansion, by Type USD Million (2024-2029)
  • Table 182. China Cell Expansion, by Application USD Million (2024-2029)
  • Table 183. China Cell Expansion, by End User USD Million (2024-2029)
  • Table 184. China Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 185. Japan Cell Expansion, by Type USD Million (2024-2029)
  • Table 186. Japan Cell Expansion, by Application USD Million (2024-2029)
  • Table 187. Japan Cell Expansion, by End User USD Million (2024-2029)
  • Table 188. Japan Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 189. India Cell Expansion, by Type USD Million (2024-2029)
  • Table 190. India Cell Expansion, by Application USD Million (2024-2029)
  • Table 191. India Cell Expansion, by End User USD Million (2024-2029)
  • Table 192. India Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 193. South Korea Cell Expansion, by Type USD Million (2024-2029)
  • Table 194. South Korea Cell Expansion, by Application USD Million (2024-2029)
  • Table 195. South Korea Cell Expansion, by End User USD Million (2024-2029)
  • Table 196. South Korea Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 197. Taiwan Cell Expansion, by Type USD Million (2024-2029)
  • Table 198. Taiwan Cell Expansion, by Application USD Million (2024-2029)
  • Table 199. Taiwan Cell Expansion, by End User USD Million (2024-2029)
  • Table 200. Taiwan Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 201. Australia Cell Expansion, by Type USD Million (2024-2029)
  • Table 202. Australia Cell Expansion, by Application USD Million (2024-2029)
  • Table 203. Australia Cell Expansion, by End User USD Million (2024-2029)
  • Table 204. Australia Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 205. Rest of Asia-Pacific Cell Expansion, by Type USD Million (2024-2029)
  • Table 206. Rest of Asia-Pacific Cell Expansion, by Application USD Million (2024-2029)
  • Table 207. Rest of Asia-Pacific Cell Expansion, by End User USD Million (2024-2029)
  • Table 208. Rest of Asia-Pacific Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 209. Europe Cell Expansion, by Country USD Million (2024-2029)
  • Table 210. Europe Cell Expansion, by Type USD Million (2024-2029)
  • Table 211. Europe Cell Expansion, by Application USD Million (2024-2029)
  • Table 212. Europe Cell Expansion, by End User USD Million (2024-2029)
  • Table 213. Europe Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 214. Germany Cell Expansion, by Type USD Million (2024-2029)
  • Table 215. Germany Cell Expansion, by Application USD Million (2024-2029)
  • Table 216. Germany Cell Expansion, by End User USD Million (2024-2029)
  • Table 217. Germany Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 218. France Cell Expansion, by Type USD Million (2024-2029)
  • Table 219. France Cell Expansion, by Application USD Million (2024-2029)
  • Table 220. France Cell Expansion, by End User USD Million (2024-2029)
  • Table 221. France Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 222. Italy Cell Expansion, by Type USD Million (2024-2029)
  • Table 223. Italy Cell Expansion, by Application USD Million (2024-2029)
  • Table 224. Italy Cell Expansion, by End User USD Million (2024-2029)
  • Table 225. Italy Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 226. United Kingdom Cell Expansion, by Type USD Million (2024-2029)
  • Table 227. United Kingdom Cell Expansion, by Application USD Million (2024-2029)
  • Table 228. United Kingdom Cell Expansion, by End User USD Million (2024-2029)
  • Table 229. United Kingdom Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 230. Netherlands Cell Expansion, by Type USD Million (2024-2029)
  • Table 231. Netherlands Cell Expansion, by Application USD Million (2024-2029)
  • Table 232. Netherlands Cell Expansion, by End User USD Million (2024-2029)
  • Table 233. Netherlands Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 234. Rest of Europe Cell Expansion, by Type USD Million (2024-2029)
  • Table 235. Rest of Europe Cell Expansion, by Application USD Million (2024-2029)
  • Table 236. Rest of Europe Cell Expansion, by End User USD Million (2024-2029)
  • Table 237. Rest of Europe Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 238. MEA Cell Expansion, by Country USD Million (2024-2029)
  • Table 239. MEA Cell Expansion, by Type USD Million (2024-2029)
  • Table 240. MEA Cell Expansion, by Application USD Million (2024-2029)
  • Table 241. MEA Cell Expansion, by End User USD Million (2024-2029)
  • Table 242. MEA Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 243. Middle East Cell Expansion, by Type USD Million (2024-2029)
  • Table 244. Middle East Cell Expansion, by Application USD Million (2024-2029)
  • Table 245. Middle East Cell Expansion, by End User USD Million (2024-2029)
  • Table 246. Middle East Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 247. Africa Cell Expansion, by Type USD Million (2024-2029)
  • Table 248. Africa Cell Expansion, by Application USD Million (2024-2029)
  • Table 249. Africa Cell Expansion, by End User USD Million (2024-2029)
  • Table 250. Africa Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 251. North America Cell Expansion, by Country USD Million (2024-2029)
  • Table 252. North America Cell Expansion, by Type USD Million (2024-2029)
  • Table 253. North America Cell Expansion, by Application USD Million (2024-2029)
  • Table 254. North America Cell Expansion, by End User USD Million (2024-2029)
  • Table 255. North America Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 256. United States Cell Expansion, by Type USD Million (2024-2029)
  • Table 257. United States Cell Expansion, by Application USD Million (2024-2029)
  • Table 258. United States Cell Expansion, by End User USD Million (2024-2029)
  • Table 259. United States Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 260. Canada Cell Expansion, by Type USD Million (2024-2029)
  • Table 261. Canada Cell Expansion, by Application USD Million (2024-2029)
  • Table 262. Canada Cell Expansion, by End User USD Million (2024-2029)
  • Table 263. Canada Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 264. Mexico Cell Expansion, by Type USD Million (2024-2029)
  • Table 265. Mexico Cell Expansion, by Application USD Million (2024-2029)
  • Table 266. Mexico Cell Expansion, by End User USD Million (2024-2029)
  • Table 267. Mexico Cell Expansion, by Cell Type USD Million (2024-2029)
  • Table 268. Cell Expansion: by Type(USD/Units)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cell Expansion: by Type USD Million (2018-2023)
  • Figure 5. Global Cell Expansion: by Application USD Million (2018-2023)
  • Figure 6. Global Cell Expansion: by End User USD Million (2018-2023)
  • Figure 7. Global Cell Expansion: by Cell Type USD Million (2018-2023)
  • Figure 8. South America Cell Expansion Share (%), by Country
  • Figure 9. Asia Pacific Cell Expansion Share (%), by Country
  • Figure 10. Europe Cell Expansion Share (%), by Country
  • Figure 11. MEA Cell Expansion Share (%), by Country
  • Figure 12. North America Cell Expansion Share (%), by Country
  • Figure 13. Global Cell Expansion: by Type USD/Units (2018-2023)
  • Figure 14. Global Cell Expansion share by Players 2023 (%)
  • Figure 15. Global Cell Expansion share by Players (Top 3) 2023(%)
  • Figure 16. Global Cell Expansion share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 21. Becton, Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 22. Terumo BCT (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Terumo BCT (Japan) Revenue: by Geography 2023
  • Figure 24. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Merck KGaA (Germany) Revenue: by Geography 2023
  • Figure 26. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Danaher Corporation (United States) Revenue: by Geography 2023
  • Figure 28. Miltenyi Biotec (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Miltenyi Biotec (Germany) Revenue: by Geography 2023
  • Figure 30. Lonza Group Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Lonza Group Ltd. (Switzerland) Revenue: by Geography 2023
  • Figure 32. STEMCELL Technologies Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 33. STEMCELL Technologies Inc. (Canada) Revenue: by Geography 2023
  • Figure 34. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 35. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 36. Corning, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Corning, Inc. (United States) Revenue: by Geography 2023
  • Figure 38. Global Cell Expansion: by Type USD Million (2024-2029)
  • Figure 39. Global Cell Expansion: by Application USD Million (2024-2029)
  • Figure 40. Global Cell Expansion: by End User USD Million (2024-2029)
  • Figure 41. Global Cell Expansion: by Cell Type USD Million (2024-2029)
  • Figure 42. South America Cell Expansion Share (%), by Country
  • Figure 43. Asia Pacific Cell Expansion Share (%), by Country
  • Figure 44. Europe Cell Expansion Share (%), by Country
  • Figure 45. MEA Cell Expansion Share (%), by Country
  • Figure 46. North America Cell Expansion Share (%), by Country
  • Figure 47. Global Cell Expansion: by Type USD/Units (2024-2029)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Terumo BCT (Japan)
  • Merck KGaA (Germany)
  • Danaher Corporation (United States)
  • Miltenyi Biotec (Germany)
  • Lonza Group Ltd. (Switzerland)
  • STEMCELL Technologies Inc. (Canada)
  • GE Healthcare (United States)
  • Corning, Inc. (United States)
Additional players considered in the study are as follows:
STEMCELL Technologies, Inc. (Canada) , Sigma-Aldrich Corporation (United States) , Miltenyi Biotec GmbH (Germany) , Lonza Group Ltd. (Switzerland) , ATEM Therapeutics (Germany)
Select User Access Type

Key Highlights of Report


Jan 2024 201 Pages 80 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cell Expansion Quantitative research analysis
Global Cell Expansion Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific, Inc. (United States), Becton, Dickinson and Company (United States), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (United States), Miltenyi Biotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (United States) and Corning, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing GMP Certifications for Cell Therapy Production Facilities " is seen as one of major influencing trends for Cell Expansion Market during projected period 2023-2029.
The Cell Expansion market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Cell Expansion Report?

Have a Query? Click Here

Other Related Reports

Acute Myeloid Leukemia Therapeutics Comprehensive Study by Type (Pipeline Drugs, Chemotherapy Drugs, Chemotherapy Regimens), Application (Hospitals, Clinics, Home Care), Drug Type (Bosutinib, Vidaza,...
$ 3750
Alopecia Comprehensive Study by Type (Oral treatment, Topical treatment, Other treatment), Application (Homecare Settings, Dermatology Clinics, Others (Salons)), Treatment (Vitamins and Supplements, ...
$ 3450
Endometriosis Treatment Comprehensive Study by Type (Gonadotropins releasing hormone agonists, Progestin, Non-steroidal anti-inflammatory drugs, Oral contraceptive pills), Application (Hospital pharm...
$ 3450
Pet Cancer Therapeutics Comprehensive Study by Type (Chemotherapy Drugs, Vaccines), Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary, Squamous Cell Cancer, Others), Treatment (Chemotherapy,...
$ 3450
Influenza Diagnostics Comprehensive Study by Type (Rapid Influenza Diagnostic Tests (RIDT), Direct Fluorescent Antibody (DFA) Tests, Molecular Diagnostic Tests, Traditional Diagnostic Tests, Viral Cu...
$ 3450
Prosthetic Heart Valves Comprehensive Study by Type (Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve), End User (Hospitals, Ambulatory Surgical Centers, Others) Players and Regi...
$ 3500